Nio on Wednesday launched the Onvo L60 EV, which aims squarely at the Tesla Model Y while targeting China's mass market for growth. Nio stock sank as U.S.-China tensions resurfaced. Tesla stock also fell.
The veteran MP for Hackney North and Stoke Newington was given the Labour whip back on Tuesday
GAITHERSBURG, Md., May 29, 2024 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that members of the Company’s management team will participate and be available for 1x1 meetings at the following investor conferences: Jefferies Global Healthcare Conference (New York, NY)Wednesday, June 5, 2024Fireside Chat at 2:00 p.m. Eastern TimeGoldman Sachs Global Healthcare Conference (Miami Beach, FL)Wednesday, June 12, 2024Fireside Chat at 9:20
ConocoPhillips (COP) has struck a deal to acquire Marathon Oil (MRO) in a $22.5 billion all-stock deal. The deal includes over $5 billion in net debt. In the airline sector, America Airlines (AAL) is sinking this morning after the company slashed its outlook for the second quarter. The move is dragging on other big names in the sector. On Wall Street, investors are focused on the Nasdaq (^IXIC) after it breached 17,000 for the first time Tuesday largely due to a jump in Nvidia (NVDA). Yahoo Finance trending tickers include GameStop (GME), DraftKings (DKNG), and Celsius Holdings (CELH). Key guests include:9:00 a.m. ET - Kate El-Hillow, Russell Investments President and Chief Investment Officer9:45 a.m. ET - Mauricio Serna, UBS Equity Research Analyst10:00 a.m. ET - Paul Sankey, Sankey Research President & Lead Analyst10:20 a.m. ET - Sumit Singh, Chewy CEO
GAITHERSBURG, Md., May 29, 2024 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that new data on the anti-inflammatory and anti-fibrotic properties of pemvidutide in subjects with metabolic dysfunction-associated steatotic liver disease (MASLD) will be presented at the EASL International Liver Congress™ 2024 in Milan, Italy. Pemvidutide is a novel, investigational, peptide-based GLP-1/glucagon dual receptor agonist in development for
New Kids Ready-to-Drink Plant-Powered Shakes Now Available in Over 300 Locations Nationwide VANCOUVER, British Columbia, May 29, 2024 (GLOBE NEWSWIRE) -- ELSE NUTRITION HOLDINGS INC. (BABY) (BABYF) (0YL.F) ("Else" or the "Company"), is proud to announce the expansion of its product line at Canada’s largest grocery chain. Following the successful introduction of Else Nutrition’s powder Kids Shakes and Toddler formulas, available in 500 stores across Canada, the company is now launching its innova
TORONTO, May 29, 2024 (GLOBE NEWSWIRE) -- Pasinex Resources Limited (CSE: PSE) (FSE: PNX) (the “Company” or “Pasinex”), is providing an update on the status of two separate legal actions initiated by its fully owned Turkish subsidiary Pasinex Arama ve Madencilik Anonim Sirketi (“Pasinex Türkiye”). In connection with the annual shareholders meeting of Horzum Maden Arama ve Isletme Anonim Sirketi (“Horzum AS”), the joint venture between Pasinex Türkiye and Akmetal Madencilik Sanayi ve Ticaret Anon
WARMINSTER, Pa., May 29, 2024 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop a functional cure for people with chronic hepatitis B virus (cHBV) infection, today announced that the Arbutus management team will present at and host one-on-one meetings at the following upcoming investor conference being held in New York: Jefferies Global Healthcare Conference: Formal Presentation on J
BRIDGEWATER, N.J., May 29, 2024 (GLOBE NEWSWIRE) -- Vyluma, Inc. (“Vyluma”), a biopharmaceutical company dedicated to advancing novel ophthalmic solutions for refractive errors, announced today that the European Medicines Agency (EMA) has validated the Marketing Authorisation Application (MAA) for its lead compound, NVK002. The application is confirmed to be eligible for a Paediatric Use Marketing Authorisation (PUMA), providing 10 years of data exclusivity and marketing protection upon product
QUEBEC CITY, Canada, May 29, 2024 (GLOBE NEWSWIRE) -- LeddarTech Holdings Inc. (“LeddarTech”) (Nasdaq: LDTC), an automotive software company that provides patented disruptive AI-based low-level sensor fusion and perception software technology, LeddarVision™, for ADAS, AD and parking applications, is pleased to announce that Frantz Saintellemy, President and Chief Executive Officer, and Chris Stewart, Chief Financial Officer, will be representing LeddarTech at two prestigious investor conferences
THE WOODLANDS, Texas, May 29, 2024 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced its participation in the Jefferies Global Healthcare Conference. Jeff Wade, Lexicon’s president and chief financial officer and Craig Granowitz, M.D., Ph.D., Lexicon’s senior vice president and chief medical officer, will participate in a moderated discussion on Wednesday, June 5, 2024, at 3:00 pm ET. A simultaneous webcast will be available in the “Events” section of the Lexicon w
To Nasdaq Copenhagen A/S Executive Management Bernstorffsgade 40 DK-1577 København V www.rd.dk Telephone +45 7012 5300 29 May 2024 Company announcement number 41/2024 Result of auction of mortgage covered bonds (SDRO’s) in series 11F, 12E and 12F Today, Realkredit Danmark has completed the auctions of mortgage covered bonds (SDRO’s) in series 11F, 12E and 12F for the refinancing of FlexKort®, RD Cibor6® Green and RD Cibor6® as of 1 July 2024. The result of the auctions is set out in the appendix
TORONTO, Ontario, May 29, 2024 (GLOBE NEWSWIRE) -- Titan Medical Inc. (“Titan”) (TSX: TMD; OTC: TMDIF) is pleased to announce that it has entered into an amending agreement dated May 28, 2024 (the “Amending Agreement”), in respect of the previously announced amalgamation agreement dated March 17, 2024 (the “Amalgamation Agreement”) among Conavi Medical Inc. (“Conavi”), 1000824255 Ontario Inc. (a wholly-owned subsidiary of Titan) and Titan, to result in the merger of Conavi and Titan (the “Propos
SAN DIEGO, May 29, 2024 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced its participation in Jefferies Global Healthcare Conference. Troy Wilson, Ph.D., J.D., President and Chief Executive Officer, is scheduled to participate in a virtual fireside chat at 3:00 p.m. ET / 12:00 p.m. PT on June 5, 2024. A live audio webcast of the fireside chat wi
Concerned Dentalcorp Will Remain Grossly Undervalued in the Public Markets Strongly Believes a Sale Would Maximize Value for All Shareholders MIAMI BEACH, Fla., May 29, 2024 (GLOBE NEWSWIRE) -- Buckley Capital Management, LLC, which together with its affiliates beneficially owns approximately 1.4% of the shares of Dentalcorp Holdings Ltd. (TSX: DNTL) (“DNTL” or the “Company”), today issued an open letter to DNTL’s board of directors and management urging them to launch a strategic review process
TORONTO, May 29, 2024 (GLOBE NEWSWIRE) -- Golconda Gold Ltd. (“Golconda Gold” or the “Company”) (TSX-V: GG; OTCQB: GGGOF) is pleased to announce the release of its financial results for the three months ended March 31, 2024. A copy of the unaudited condensed consolidated interim financial statements for the three months ended March 31, 2024, prepared in accordance with International Financial Reporting Standards, and the corresponding management’s discussion and analysis (the “MD&A”), are availa
NEW YORK, May 29, 2024 (GLOBE NEWSWIRE) -- Lotus Technology Inc. (“Lotus Tech” or the “Company”) (Nasdaq: LOT), a leading global luxury electric vehicle maker, today released its 2023 Environmental, Social, and Governance (“ESG”) report. The report outlined its achievements in building a green value chain, leading clean mobility, and upholding business integrity through the efforts in information security and privacy protection as well as in community support. All information disclosed in the re
WINTER PARK, Fla., May 29, 2024 (GLOBE NEWSWIRE) -- Alpine Income Property Trust, Inc. (NYSE: PINE) (the “Company”) announced today a correction to the ex-dividend date previously announced on May 28, 2024. The ex-dividend date for the quarterly cash dividend per share of common stock for the second quarter of 2024 has been corrected from June 12, 2024 to June 13, 2024. All other details remain unchanged. About Alpine Income Property Trust, Inc. Alpine Income Property Trust, Inc. (NYSE: PINE) is
WASHINGTON, May 29, 2024 (GLOBE NEWSWIRE) -- FTI Consulting, Inc. (NYSE: FCN) today announced the appointment of Michael Spadea as a Senior Managing Director and North America Leader of the Information Governance, Privacy and Security practice within the firm’s Technology segment. Mr. Spadea, who is based in Seattle, helps clients obtain value from their data by building strong governance programs that mitigate digital risk while enabling growth. Mr. Spadea supports organizations across industri
Oracle Health partnership enables 400-bed, southern California health system to leverage RevID’s automated charge reconciliation for improved financial performanceAtlanta, May 29, 2024 (GLOBE NEWSWIRE) -- – Streamline Health Solutions, Inc. (NASDAQ: STRM), a leading provider of solutions that enable healthcare providers to improve financial performance, announced that it has signed a new contract for the use of RevID, with a 400-bed, Oracle Cerner-EHR based health system with facilities in South
TORONTO, May 29, 2024 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”), an innovative global cannabinoid company, today announced that Mike Gorenstein, Chairman, President and CEO, will speak at Bernstein's 40th Annual Strategic Decisions Conference on Thursday, May 30, 2024, at 2:30PM ET. A live webcast will be available on the Investors section of the Company’s website at https://ir.thecronosgroup.com/events-presentations. About Cronos Group Inc.Cron
Yahoo Finance